Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alger Growth Opportunities Fund Class C (AOFCX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund invests primarily in the stock of small, fast-growing companies that Fred Alger Management, Inc. believes offer innovative products, services or technologies to a rapidly-expanding marketplace. Although it may invest without limit in companies of any size, the fund focuses on companies that, at the time of purchase of the securities, have a total market capitalization not exceeding the highest market capitalization of companies included in the Russell 2500 Growth Index, as reported by the index as of the most recent quarter-end.


1 month+2.72% 3 years+16.88%
3 months+5.50% 5 years+14.91%
1 year+17.28% Since inception+7.84%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+14.91%+17.65%
Expense ratio2.99%1.37%
Risk 5 year sharpe ratio0.951.05
Net assets$34.9M$835.3M
Average market cap$1.9B$2.9B
Average P/E37.828.2
Portfolio turnover92%92%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAlger
Fund manager & tenureAmy Zhang / 0 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00


U.S. stock91.82%
International stock2.08%
Fixed income0.27%
Top 5 Sectors
Portfolio weighting
Industrial materials 16.26%
Healthcare 15.89%
Consumer service 10.44%
Business service 10.05%
Hardware 8.22%
Top 10 Holdings
Portfolio weighting
MDSO Medidata Solutions Inc3.46%
ABAX Abaxis Inc3.24%
ACIW ACI Worldwide Inc3.15%
PRLB Proto Labs Inc3.10%
DTSI DTS Inc3.08%
DWRE Demandware Inc3.05%
TECH Bio-Techne Corp2.99%
NEOG Neogen Corp2.98%
BCPC Balchem Corp2.88%
CMN Cantel Medical Corp2.88%